By Kat Greene ( October 4, 2017, 9:12 PM EDT) -- A California federal judge found Wednesday that Boston Scientific Corp. couldn't claim that medical device maker Nevro Inc.'s failure to correct a patent examiner's misunderstanding of prior art was inequitable conduct, though the judge had said in an earlier hearing the tactic "may be a little sleazy."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.